Orbimed Advisors - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 3 filers reported holding SEATTLE GENETICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q4 2014$3,213,000
-48.9%
100,000
-50.0%
0.03%
-76.7%
Q2 2013$6,292,000200,0000.13%
Other shareholders
SEATTLE GENETICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Lagoda Investment Management, L.P. 57,170$10,013,0005.39%
Boxer Capital, LLC 400,000$70,056,0002.25%
PARTNERS CAPITAL INVESTMENT GROUP, LLP 110,153$19,292,0001.10%
DCF Advisers, LLC 13,300$2,329,0000.96%
XTX MARKETS LLC 2,418$423,0000.87%
FAIRFIELD, BUSH & CO. 15,035$2,633,0000.77%
Parcion Private Wealth LLC 4,520$792,0000.10%
Gulf International Bank (UK) Ltd 26,091$4,569,0000.06%
Princeton Portfolio Strategies Group LLC 1,500$263,0000.05%
Redpoint Investment Management Pty Ltd 2,392$419,0000.04%
View complete list of SEATTLE GENETICS INC shareholders